DKSH has acquired two ear care brands, Audisol and Audiplugs, from Noru Pharma to enhance its Healthcare Own Brands business and expand its presence in Australia, New Zealand, and select Asian markets.
Target Information
DKSH has entered into an agreement to acquire two ear care brands from Noru Pharma, namely Audisol and Audiplugs, specifically for the markets of Australia, New Zealand, and selected regions in Asia. Audisol specializes in ear treatment products aimed at addressing daily ear care needs, while Audiplugs offers a complete range of high-quality earplugs. Both brands have established a presence in Australia, New Zealand, and Singapore, with plans for DKSH to gradually expand their availability to additional markets.
Industry Overview in Australia and New Zealand
The ear care market in Australia and New Zealand is characterized by a significant demand for healthcare products that cater to personal hygiene and preventive care. As awareness regarding ear health continues to grow, consumers are increasingly seeking effective and reliable products in this niche. This trend drives market players to innovate and enhance their offerings, leading to a competitive landscape.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Over-the-counter (OTC) health products, including ear care solutions, have been experiencing consistent growth in Australia and New Zealand. Factors such as an aging population, active lifestyles, and rising health co
Similar Deals
Barwon Healthcare Property Fund → Two fully leased medical centres
2021
PERKii Targeted Release Probiotics → ProGel Microgel Technology Pty Ltd
DKSH
invested in
Noru Pharma's ear care brands
in 2022
in a Other deal
Disclosed details
Revenue: $2M